Objective
This mobility program will advance research and innovation (R&I) in Human immunodeficiency virus (HIV) persistence by partnering European and African institutions to co-develop robust, reproducible pipelines spanning ex vivo and reservoir assays, organoid based pharmacology, multi-omics integration, geospatial science, and artificial intelligence (AI) driven analytics. European R&I infrastructure capacity and established clinical cohorts, accredited laboratories, and proven assays already operationalized in African partner institutions, the project will generate calibrated feature sets to define reproducible immunological and molecular endotypes that inform long-acting antiretroviral therapy (LA-ART) and “block-and-lock” therapeutic strategies while creating opportunities for interdisciplinary, international and intersectoral transfer of knowledge. This will result to improved understanding of HIV reservoirs and positively impact capacity of EU researchers facilitated by bidirectional staff-exchanges across sectors and regions, pairing hands-on laboratory and clinical method transfer with data engineering, machine learning operations, and spatial epidemiology skills. European Countries will benefit through strengthened HIV research knowledge in implementation science, diversified evidence bases that improve the validity and generalizability of biomarkers and models across genotypes and comorbidity profiles, strengthened research infrastructures through shared protocols and reusable open tools. By pairing African established cohorts and proven assays with European strengths in infrastructure and capacity in HIV, immunology and organoid R&I, the consortium delivers durable scientific value for Europe and accelerates fair, scalable translation from discovery to policy and practice.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- medical and health sciences health sciences public health epidemiology
- natural sciences computer and information sciences data science big data
- medical and health sciences basic medicine immunology
- medical and health sciences health sciences infectious diseases RNA viruses HIV
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA Staff Exchanges
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2025-SE-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
3015 GD Rotterdam
Netherlands
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.